Cargando…

Asthma

Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and app...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Harold, Mazza, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245435/
https://www.ncbi.nlm.nih.gov/pubmed/22165976
http://dx.doi.org/10.1186/1710-1492-7-S1-S2
_version_ 1782219858423840768
author Kim, Harold
Mazza, Jorge
author_facet Kim, Harold
Mazza, Jorge
author_sort Kim, Harold
collection PubMed
description Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and appropriate pharmacological interventions. Inhaled corticosteroids (ICSs) represent the standard of care for the majority of patients. Combination ICS/long-acting beta(2)-agonists (LABA) inhalers are preferred for most adults who fail to achieve control with ICS therapy. Allergen-specific immunotherapy represents a potentially disease-modifying therapy for many patients with asthma, but should only be prescribed by physicians with appropriate training in allergy. Regular monitoring of asthma control, adherence to therapy and inhaler technique are also essential components of asthma management. This article provides a review of current literature and guidelines for the appropriate diagnosis and management of asthma.
format Online
Article
Text
id pubmed-3245435
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32454352011-12-24 Asthma Kim, Harold Mazza, Jorge Allergy Asthma Clin Immunol Review Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and appropriate pharmacological interventions. Inhaled corticosteroids (ICSs) represent the standard of care for the majority of patients. Combination ICS/long-acting beta(2)-agonists (LABA) inhalers are preferred for most adults who fail to achieve control with ICS therapy. Allergen-specific immunotherapy represents a potentially disease-modifying therapy for many patients with asthma, but should only be prescribed by physicians with appropriate training in allergy. Regular monitoring of asthma control, adherence to therapy and inhaler technique are also essential components of asthma management. This article provides a review of current literature and guidelines for the appropriate diagnosis and management of asthma. BioMed Central 2011-11-10 /pmc/articles/PMC3245435/ /pubmed/22165976 http://dx.doi.org/10.1186/1710-1492-7-S1-S2 Text en Copyright ©2011 Kim and Mazza; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kim, Harold
Mazza, Jorge
Asthma
title Asthma
title_full Asthma
title_fullStr Asthma
title_full_unstemmed Asthma
title_short Asthma
title_sort asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245435/
https://www.ncbi.nlm.nih.gov/pubmed/22165976
http://dx.doi.org/10.1186/1710-1492-7-S1-S2
work_keys_str_mv AT kimharold asthma
AT mazzajorge asthma